Par Drugs and Chemicals Limited — Important, 13-02-2025: Updates

The Extra Ordinary General Meeting (EGM) of PAR Drugs and Chemicals Limited, held via video conferencing, successfully voted on two significant resolutions. The shareholders overwhelmingly approved the slump sale of existing establishment assets, with 77.83% voting in favor, and a venture into real estate and renewable energy, receiving 78.83% approval. The remote e-voting occurred from February 9 to 11, 2025, with further in-person voting available during the EGM. The scrutinizer, Jaymeen Trivedi, confirmed the transparency and compliance of the e-voting process, alongside the involvement of independent witnesses. Overall, the resolutions were passed with a strong majority, signaling positive strategic shifts for the company, potentially enhancing its market position and new business avenues. Investors should consider this a favorable development, indicating proactive management and growth potential.